IP Library › Granted Patent US 12,461,078
Granted Patent B2
US 12,461,078 · App. 17/471,463 · Granted Nov 4, 2025

Compounds for use in system suitability testing of inert LC systems and columns

Inventors: Amit Patel (Shrewsbury, MA); Matthew A. Lauber (North Smithfield, RI); Kevin Wyndham (Upton, MA); Mathew DeLano (Needham, MA); Jennifer Simeone (Shrewsbury, MA)
Assignee: Waters Technologies Corporation
G01N30/88G01N2030/027
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,461,078
App. No.
17/471,463
Granted
Nov 4, 2025
Kind
B2
Abstract

The present disclosure is directed to a kit for evaluating system inertness. The kit includes a positive control comprising a metal interacting moiety, and a negative control that does not contain a metal interacting moiety. In some embodiments the kit also includes a container to hold a system suitability solution (e.g., an equimolar mixture of the positive control and the negative control).

Claims (27)

1 . A kit for evaluating liquid chromatography (LC) system and column inertness, the kit comprising:

a first vial comprising a positive control comprising a metal interacting moiety, wherein the positive control is selected from the group consisting of 2′(3′)-O-(4-Benzoylbenzoyl) adenosine 5′- triphosphate (Bz-ATP), ATP labeled with 6-aminohexyladenosine, ATP labeled with methylanthraniloyl, ATP labeled with trinitrophenyl, ATP labeled with fluorescein, and ATP labeled with pyrene; and

a second vial comprising a negative control comprising caffeine, the negative control not containing a metal interacting moiety, wherein both the positive control and the negative control are used as probe compounds for the detection of exposed metal in LC system and column.

2 . A kit for evaluating liquid chromatography (LC) system and column inertness, the kit comprising:

a first vial comprising a positive control comprising a metal interacting moiety, wherein the positive control is ATP or a chemical analog thereof; and

a second vial comprising a negative control comprising adenosine, the negative control not containing a metal interacting moiety, wherein both the positive control and the negative control are used as probe compounds for the detection of exposed metal in LC system and column.

3 . The kit of claim 1 , wherein the positive control consists of Bz-ATP.

4 . The kit of claim 2 , wherein the first vial and the second vial comprise equimolar amounts of the positive control and the negative control, respectively.

5 . A kit for evaluating liquid chromatography (LC) system and column inertness, the kit comprising:

a positive control comprising a metal interacting moiety, wherein the positive control is adenosine 5′-(α, β-methylene) diphosphate (AMPcP) or a chemical analog thereof;

a negative control comprising adenosine or caffeine and that does not contain a metal interacting moiety, wherein both the positive control and the negative control are used as probe compounds for the detection of exposed metal in LC system and column; and

a container to hold a system suitability solution.

6 . The kit of claim 5 , wherein the negative control consists of adenosine or substantially adenosine.

7 . The kit of claim 5 , wherein the negative control consists of caffeine or substantially caffeine.

8 . The kit of claim 5 , wherein the system suitability solution comprises an equimolar mixture of the negative control and the positive control.

9 . The kit of claim 2 , wherein the positive control comprises a chemical analog of ATP, and the chemical analog of ATP is 2′(3′)-O-(4-Benzoylbenzoyl) adenosine 5′-triphosphate (Bz-ATP).

10 . The kit of claim 2 , wherein the positive control comprises a chemical analog of ATP, and the chemical analog of ATP is etheno adenosine 5′-(α,β- methylene) diphosphate with the following structure:

11 . The kit of claim 2 , wherein the positive control comprises a chemical analog of ATP, and the chemical analog of ATP is 6-aminohexyladenosine.

12 . The kit of claim 2 , wherein the positive control comprises a chemical analog of ATP, and the chemical analog of ATP is 2-aminopurine.

13 . The kit of claim 2 , wherein the positive control comprises a chemical analog of ATP, and the chemical analog of ATP is ATP labeled with methylanthraniloyl.

14 . The kit of claim 2 , wherein the positive control comprises a chemical analog of ATP, and the chemical analog of ATP is ATP labeled with trinitrophenyl.

15 . The kit of claim 2 , wherein the positive control comprises a chemical analog of ATP, and the chemical analog of ATP is ATP labeled with fluoroscein.

16 . The kit of claim 2 , wherein the positive control comprises a chemical analog of ATP, and the chemical analog of ATP is ATP labeled with pyrene.

17 . The kit of claim 2 , wherein the negative control and the positive control have different spectral properties.

18 . A kit for evaluating liquid chromatography (LC) system and column inertness, the kit comprising:

a first vial comprising a positive control comprising a metal interacting moiety, wherein the positive control is etheno adenosine 5′-(α,β-methylene) diphosphate or ATP labeled with 2-aminopurine; and

a second vial comprising a negative control comprising caffeine, the negative control not containing a metal interacting moiety, wherein both the positive control and the negative control are used as probe compounds for the detection of exposed metal in LC system and column.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 17, 2023
From: PATEL, AMIT; JUNG, MOON CHUL; RZEWUSKI, SUSAN; LAUBER, MATTHEW A.; WALTER, THOMAS H.; WYNDHAM, KEVIN; DELANO, MATHEW; SIMEONE, JENNIFER
To: WATERS TECHNOLOGIES CORPORATION
Reel/Frame 062733/0761 →
Continuity (3)
Provisional Application 63079151 · Sep 16, 2020
Provisional Application 63079160 · Sep 16, 2020
Related Publication 20220091079A1 · Mar 24, 2022
References Cited (12)
US 6703211B1 · Shultz · 2004 [cited by examiner]
US 20060027098A1 · Lautamo · 2006 [cited by applicant]
US 20120100120A1 · Ferrante · 2012 [cited by examiner]
US 20200215457A1 · DeLano et al. · 2020 [cited by applicant]
US 20200217827A1 · Liu et al. · 2020 [cited by applicant]
WO WO2004030621A2 · 2004 [cited by examiner]
Sigma-Aldrich Adenosine 5'-triphosphate (ATP) Bioluminescent Assay Kit Product Information Sheet (Year: 2024). [cited by examiner]
Sigma Aldrich Caffeine, https://www.sigmaaldrich.com/US/en/product/sial/c0750?srsltid=AfmBOopjxDTdrNSL40dMyYf4vGBUrxqsGTxV-bZZZtXUdQGJeGko6G3R Accessed Oct. 30, 2024. (Year: 2024). [cited by examiner]
Alonso, M.T. et al. (2003). “Fura-2 antagonises calcium-induced calcium release.” Cell Calcium. 33. 27-35. (Year: 2003). [cited by examiner]
Invitation to Pay Additional Fees and, Where Applicable, Protest Fee issued in International Applications No. PCT/IB2021/058260 dated Dec. 9, 2021. [cited by applicant]
Wright et al. “New method for evaluating irreversible adsorption and stationary phase bleed in gas chromatographic capillary columns.” J. Chromatogr. A. 1261(2012): 142-150. [cited by applicant]
Zenkevich et al. “Inertness Criterion for Gas-Chromatographic Systems.” J. Anal. Chem. 69.12(2014): 1130-1140. [cited by applicant]